Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20113825

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2010 Jan 30
First author
Gianni L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Jan 30;375(9712):349-50. doi: 10.1016/S0140-6736(09)62069-9.
    note
    Source null
    related pmid
    20113810
    relationship
    Comment in

Authors and identifiers

  1. name
    Gianni L
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Semiglazov V
    type
    Author
  4. name
    Manikhas A
    type
    Author
  5. name
    Lluch A
    type
    Author
  6. name
    Tjulandin S
    type
    Author
  7. name
    Zambetti M
    type
    Author
  8. name
    Vazquez F
    type
    Author
  9. name
    Byakhow M
    type
    Author
  10. name
    Lichinitser M
    type
    Author
  11. name
    Climent MA
    type
    Author
  12. name
    Ciruelos E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gianni L
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Semiglazov V
    type
    Author
  4. name
    Manikhas A
    type
    Author
  5. name
    Lluch A
    type
    Author
  6. name
    Tjulandin S
    type
    Author
  7. name
    Zambetti M
    type
    Author
  8. name
    Vazquez F
    type
    Author
  9. name
    Byakhow M
    type
    Author
  10. name
    Lichinitser M
    type
    Author
  11. name
    Climent MA
    type
    Author
  12. name
    Ciruelos E
    type
    Author
bibliography ids
  1. nci-bib-d4ebd01d39ee19ecba3e6bf4
book metadata
content sha256
919c05abb49c2d7849ce3bd5cb845db0efdc7130f9d88493f5eecb26815cb0c1
document type
citation
dois
  1. 10.1016/S0140-6736(09)61964-4
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:20113825
immutable id
pubmed:20113825@919c05abb49c2d7849ce3bd5cb845db0efdc7130f9d88493f5eecb26815cb0c1
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9712
name
Lancet (London, England)
nlm unique id
2985213R
pages
377-84
volume
375
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Jan 30;375(9712):349-50. doi: 10.1016/S0140-6736(09)62069-9.
    note
    Source null
    related pmid
    20113810
    relationship
    Comment in
outcomes validated
false
pmid
20113825
provenance
batch id
708c7929ee1eff455330
provider
NCBI PubMed ESummary
record sha256
77672ed0c3cbbe5e7148702f5fe8cff778f5027f84a3c33c5880d056241b2180
response sha256
d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
retrieved at
2026-09-09T23:46:31.496840+00:00
publication date
display
2010 Jan 30
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20113825/
title
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Preserved source evidence · Not medical advice